Stem Cell Therapy for Peripheral Artery Disease – Improving Blood Flow

album-art
00:00
Sorry, no results.
Please try another keyword

The Stem Cell Medical Center in Antigua provides cutting-edge stem cell treatments to patients from around the world. One condition they effectively treat is peripheral artery disease (PAD), which impairs circulation in the limbs. This article explains how their stem cell therapy can regenerate blood vessels and restore vascular function for PAD patients.

Understanding Peripheral Artery Disease (PAD)

  • PAD arises when fatty deposits clog arteries supplying the legs and arms.
  • As vessels narrow, blood flow declines, depriving tissues of oxygen and nutrients.
  • Patients endure extreme pain, non-healing wounds, gangrene and high amputation risk.
  • PAD prevalence approaches 10% in those over 70 years old.
  • Diabetes drives PAD progression by harming blood vessels.
  • Over half of critical limb ischemia patients face amputation or death within a year of diagnosis despite modern interventions.
  • Thus, better therapies are desperately needed.

How Stem Cells Repair Blood Vessels

Stem cells are master cells producing all other cell types during growth and healing. Researchers discovered adult stem cell infusion can regenerate circulatory function in damaged or blocked blood vessels.

Mesenchymal stem cells (MSCs) show particular promise for treating PAD. These multipotent cells occur in various tissues and differentiate into vascular support cells. Transplanted MSCs also secrete growth factors that stimulate vessel regrowth.

For PAD patients, MSC injection into limb tissues can recreate thousands of tiny collateral conduits around blocked arteries. Oxygenated blood flow reroutes through new paths restoring nourishment to ailing extremities.

Bone Marrow MSCs for PAD Treatment

Early PAD trials focused on bone marrow stem cells containing plentiful MSCs and blood stem cells. Patients receiving injections showed marked reductions in pain, increased lower limb oxygenation and growing collateral vessels on imaging.

However, bone marrow aspiration is painful. Older, sicker PAD patients often harbor less potent marrow cells. Processing individual batches takes weeks before therapeutic use.

The Promise of Umbilical Cord MSCs

The Stem Cell Medical Center circumvents such limitations by employing allogeneic umbilical cord MSCs. Retrieved after birth, abundant young cord blood cells offer an off-the-shelf stem cell source needing no painful donations.

Compared to bone marrow MSCs, studies find cord cells more vigorously stimulate angiogenesis, new vessel growth. Optimized preparatory measures further enhance cord MSCs’ potency for regenerating ischemic tissues.

Stem Cell Therapy Process and Experience

Upon arriving at the Stem Cell Medical Center, PAD patients first meet with medical staff reviewing their history and imaging to develop a customized treatment plan. During the appointment, patients receive intravenous umbilical cord MSC infusion to flood diseased limbs with regenerative cells.

Some return periodically for booster infusions if needed to achieve revascularization goals. Most patients feel mild infusion-related symptoms like headache or back pain resolvable with rest and medication. When medically eligible, light physical therapy also helps strengthen recovering limbs.

Conclusion

In summary, the Stem Cell Medical Center provides leading-edge stem cell therapy to PAD patients from across the globe. Their umbilical cord MSC vascular regeneration protocol offers a painless, effective way to grow new collateral blood conduits saving threatened limbs. Contact their exceptional team today to see if their treatments are right for your peripheral artery disease.